Our observations are consistent with recent case reports and series describing pregnancy-associated complement-mediated HUS precipitated by severe obstetric complications, including postpartum hemorrhage, HELLP syndrome and sepsis, in which delayed recognition of TMA and restricted access to C5 inhibitors were associated with poor renal outcomes and a high rate of dialysis dependence [5,8]. Here, C5 is linked to hemorrhage.